Amy Levin

Amy Levin has extensive work experience in the pharmaceutical and biotech industry. Amy currently holds the position of Vice President of Clinical Operations at Oncolytics Biotech Inc., a role they have held since January 2023. Prior to that, they served as the Executive Director of Clinical Operations at the same company from September 2020 to January 2023.

Before joining Oncolytics Biotech Inc., Amy worked at Puma Biotechnology, Inc. as the Senior Director of Clinical Operations from December 2011 to August 2020. Amy also held the position of Director of Clinical Program Leader at The Janssen Pharmaceutical Companies of Johnson & Johnson from April 2007 to December 2011.

Amy began their career at Merck in October 2000 as a Vaccine Specialist, where they worked until April 2002. Amy then joined Amgen as a Clinical Research Manager and stayed with the company until April 2007.

Overall, Amy Levin has over 20 years of experience in various roles within the pharmaceutical and biotech industry, with a strong emphasis on clinical operations and leadership positions.

Amy Levin has a Bachelor of Science in Nursing (BSN) and is a registered nurse (RN). Amy obtained their degree from The University of Texas at Austin. No information regarding the specific years of their education is provided.